Physician profile
Ronnie Mimran
NPI 1821043498
$409,979.71
in general payments reported to CMS, 2019-2025
7 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137K · 2020: $70K · 2021: $135K · 2022: $56K · 2023: $8,497 · 2024: $4,425 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,369 · Travel and Lodging: $3,902 · Food and Beverage: $750 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,369.25 |
| Travel and Lodging | $3,902.29 |
| Food and Beverage | $749.53 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $402,318.18 | 2019-2023 | Pulse, Simplify Cervical Artificial Disc, Tlif |
| Globus Medical, INC. | $4,463.96 | 2024-2025 | Excelsiusgps Robotic Navigation System, Caliber, Excelsius3d Imaging System |
| Si-Bone, INC. | $3,000.00 | 2019 | |
| Intrinsic Therapeutics | $79.82 | 2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic USA, INC. | $58.34 | 2020 | |
| Medtronic, INC. | $39.41 | 2022 | |
| Csl Behring | $20.00 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronnie Mimran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.